BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33516580)

  • 1. Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards.
    Soltys SG; Grimm J; Milano MT; Xue J; Sahgal A; Yorke E; Yamada Y; Ding GX; Li XA; Lovelock DM; Jackson A; Ma L; El Naqa I; Gibbs IC; Marks LB; Benedict S
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):112-123. PubMed ID: 33516580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards.
    Soltys SG; Milano MT; Xue J; Tomé WA; Yorke E; Sheehan J; Ding GX; Kirkpatrick JP; Ma L; Sahgal A; Solberg T; Adler J; Grimm J; El Naqa I
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):100-111. PubMed ID: 33375955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
    Royce TJ; Mavroidis P; Wang K; Falchook AD; Sheets NC; Fuller DB; Collins SP; El Naqa I; Song DY; Ding GX; Nahum AE; Jackson A; Grimm J; Yorke E; Chen RC
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):227-236. PubMed ID: 32900561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
    Redmond KJ; Gui C; Benedict S; Milano MT; Grimm J; Vargo JA; Soltys SG; Yorke E; Jackson A; El Naqa I; Marks LB; Xue J; Heron DE; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):53-67. PubMed ID: 33390244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer.
    Mahadevan A; Moningi S; Grimm J; Li XA; Forster KM; Palta M; Prior P; Goodman KA; Narang A; Heron DE; Lo SS; Urbanic J; Herman JM
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):206-216. PubMed ID: 33358561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
    J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study.
    Guckenberger M; Sweeney RA; Hawkins M; Belderbos J; Andratschke N; Ahmed M; Madani I; Mantel F; Steigerwald S; Flentje M
    Cancer; 2018 May; 124(9):2001-2009. PubMed ID: 29499073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
    Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
    Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses.
    Wang HH; Chen Y; Liu X; Zaorsky NG; Mani K; Niu ZM; Zheng BY; Zeng HY; Yan YY; Li YJ; He Y; Ji CZ; Sun BS; Meng MB
    Radiother Oncol; 2023 Oct; 187():109817. PubMed ID: 37480993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.
    Milano MT; Grimm J; Soltys SG; Yorke E; Moiseenko V; Tomé WA; Sahgal A; Xue J; Ma L; Solberg TD; Kirkpatrick JP; Constine LS; Flickinger JC; Marks LB; El Naqa I
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):87-99. PubMed ID: 29534899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy for de novo spinal metastases: systematic review.
    Husain ZA; Sahgal A; De Salles A; Funaro M; Glover J; Hayashi M; Hiraoka M; Levivier M; Ma L; Martínez-Alvarez R; Paddick JI; Régis J; Slotman BJ; Ryu S
    J Neurosurg Spine; 2017 Sep; 27(3):295-302. PubMed ID: 28598293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system.
    Giaj-Levra N; Niyazi M; Figlia V; Napoli G; Mazzola R; Nicosia L; Corradini S; Ruggieri R; Minniti G; Alongi F
    Radiat Oncol; 2019 Oct; 14(1):184. PubMed ID: 31655620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.
    Sahgal A; Chang JH; Ma L; Marks LB; Milano MT; Medin P; Niemierko A; Soltys SG; Tomé WA; Wong CS; Yorke E; Grimm J; Jackson A
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):124-136. PubMed ID: 31606528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions.
    Nguyen EK; Ruschin M; Zhang B; Soliman H; Myrehaug S; Detsky J; Chen H; Sahgal A; Tseng CL
    J Neurooncol; 2023 May; 163(1):15-27. PubMed ID: 37155133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Radiation Therapy Fractionation Regimens for Early-Stage Non-Small Cell Lung Cancer.
    Liu F; Ververs JD; Farris MK; Blackstock AW; Munley MT
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):829-838. PubMed ID: 37734445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal hypofractionated radiation therapy schemes for early-stage hepatocellular carcinoma.
    Liu F; Brown DR; Munley MT
    Radiother Oncol; 2024 May; 194():110223. PubMed ID: 38467342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases.
    Guckenberger M; Mantel F; Sweeney RA; Hawkins M; Belderbos J; Ahmed M; Andratschke N; Madani I; Flentje M
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):348-357. PubMed ID: 33412262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery.
    Farooqi A; Bishop AJ; Narang S; Allen PK; Li J; McAleer MF; Tatsui CE; Rhines LD; Amini B; Wang XA; Ghia AJ
    Pract Radiat Oncol; 2019 Mar; 9(2):e142-e148. PubMed ID: 30385151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.